Allotment of Equity Shares Pursuant to Exercise of Options under Solara Employee Stock Option Plan 2018

Audio recordings of Q4 FY26 earnings call conducted on May 15, 2026, for the quarter and year ended March 31, 2026

Monitoring Agency Report

Adoption of Board Evaluation policy and Amendment of Whistle Blower policy

Change in Internal and Cost Auditor for FY 26-27

Disclosure under Reg. 30 – Demand Notice

Closure of wholly owned Subsidiary – Solara Active Pharma Sciences LTDA, Brazil